Organon & Co. Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	1,023	917	1,351	2,160	3,218	2,153
Depreciation & Amortization	236	212	195	142	333	1,673
Share-Based Compensation	101	75	59	40	41	56
Other Operating Activities	-561	-346	853	-155	-825	-195
Operating Cash Flow	799	858	2,458	2,187	2,767	3,687
Operating Cash Flow Growth	-6.88%	-65.09%	12.39%	-20.96%	-24.95%	-
Capital Expenditures	-250	-189	-185	-250	-88	-69
Acquisitions	-2	-124	-192	0	0	0
Other Investing Activities	-8	-107	-104	-8	-14	-
Investing Cash Flow	-260	-420	-481	-258	-102	-69
Dividends Paid	-294	-290	-145	0	0	0
Debt Issued / Paid	-258	-108	7,728	1,512	0	59
Other Financing Activities	-17	-35	-8,916	-3,687	-2,621	-4,223
Financing Cash Flow	-569	-433	-1,333	-2,175	-2,621	-4,164
Exchange Rate Effect	17	-36	23	-3	31	19
Net Cash Flow	-13	-31	667	-249	75	-527
Free Cash Flow	549	669	2,273	1,937	2,679	3,618
Free Cash Flow Growth	-17.94%	-70.57%	17.35%	-27.70%	-25.95%	-
Free Cash Flow Margin	8.77%	10.84%	36.06%	29.65%	34.45%	37.01%
Free Cash Flow Per Share	2.15	2.63	8.96	7.64	10.57	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).